zonisamide has been researched along with Action Myoclonus-Renal Failure Syndrome in 3 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the safety and efficacy of zonisamide in treating myoclonic seizures associated with progressive myoclonic epilepsy (PME), in an open-label setting." | 9.13 | Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. ( Conry, JA; Murphy, JV; Vossler, DG, 2008) |
| "To examine the safety and efficacy of zonisamide in treating myoclonic seizures associated with progressive myoclonic epilepsy (PME), in an open-label setting." | 5.13 | Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. ( Conry, JA; Murphy, JV; Vossler, DG, 2008) |
| "Seizures, especially myoclonus, are often refractary to antiepileptic drugs (AD)." | 2.82 | [Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy]. ( Álvarez-Pérez, P; Cores-Bartolomé, C; Lema-Facal, T; Rubio-Nazábal, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Rubio-Nazábal, E | 1 |
| Álvarez-Pérez, P | 1 |
| Cores-Bartolomé, C | 1 |
| Lema-Facal, T | 1 |
| Herzog, R | 1 |
| Hellenbroich, Y | 1 |
| Brüggemann, N | 1 |
| Lohmann, K | 1 |
| Grimmel, M | 1 |
| Haack, TB | 1 |
| von Spiczak, S | 1 |
| Münchau, A | 1 |
| Vossler, DG | 1 |
| Conry, JA | 1 |
| Murphy, JV | 1 |
1 review available for zonisamide and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
[Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
Topics: Anticonvulsants; Humans; Lafora Disease; Myoclonic Epilepsies, Progressive; Myoclonus; Zonisamide | 2022 |
1 trial available for zonisamide and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Female; Humans; Isoxazoles; Male; Myocl | 2008 |
1 other study available for zonisamide and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
Zonisamide-responsive myoclonus in SEMA6B-associated progressive myoclonic epilepsy.
Topics: Anticonvulsants; Exome Sequencing; Female; Humans; Myoclonic Epilepsies, Progressive; Pedigree; Sema | 2021 |